Chemoinformaics analysis of 3,7-Octadien-2-one, (E)-
Molecular Weight | 124.183 | nRot | 4 |
Heavy Atom Molecular Weight | 112.087 | nRig | 3 |
Exact Molecular Weight | 124.089 | nRing | 0 |
Solubility: LogS | -1.576 | nHRing | 0 |
Solubility: LogP | 1.705 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 22.1635 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.524 |
Synth | 3.139 |
Natural Product Likeliness | 2.013 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.382 |
MDCK | 0.000027 |
BBB | 0.968 |
PPB | 0.719002 |
VDSS | 0.814 |
FU | 0.218452 |
CYP1A2-inh | 0.27 |
CYP1A2-sub | 0.583 |
CYP2c19-inh | 0.129 |
CYP2c19-sub | 0.493 |
CYP2c9-inh | 0.02 |
CYP2c9-sub | 0.844 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.886 |
CYP3a4-inh | 0.078 |
CYP3a4-sub | 0.21 |
CL | 11.151 |
T12 | 0.872 |
hERG | 0.005 |
Ames | 0.23 |
ROA | 0.029 |
SkinSen | 0.926 |
Carcinogencity | 0.179 |
EI | 0.994 |
Respiratory | 0.658 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.956486 |